Skip to content

A comparative study of two types of (Dual Peak Blue-Green Light Emitting Diode vs Single Peak Blue Light Emitting Diode) phototherapies for neonatal jaundice

Dual Peak Blue-Green Light Emitting Diode vs Single Peak Blue Light Emitting Diode phototherapy for neonatal hyperbilirubinemia- a randomized controlled trial

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2013/07/003819
Enrollment
80
Registered
2013-07-18
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Neonates with Jaundice requiring phototherapy

Interventions

Intervention1: Dual Peak Blue-Green Light Emitting Diode phototherapy: This phototherapy provides a spectral Irradiance of 35 µW/cm2/nm at 15-20 cm and wavelength of 2 peaks at 450 & 548 nm Control

Sponsors

PGIMER Chandigarh
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: All consecutive neonates >28 weeks gestation, admitted with non-hemolytic hyper-bilirubinemia requiring phototherapy in the first two weeks of life will be eligible for enrollment

Exclusion criteria

Exclusion criteria: a. Gestation less than or equal to 28 weeks of gestation b. Non- availability of at least 1 phototherapy study machine of each type. c. Clinical signs of Acute Bilirubin encephalopathy d. Serum Total Bilirubin (STB) within 3 mg/dL of the cut-off for exchange transfusion e. Babies who already underwent exchange transfusion f. Clinical evidence of hemolysis e.g. anemia, hepato-splenomegaly g. Onset of jaundice in first 24 hours of life h. Babies with lethal congenital malformations

Design outcomes

Primary

MeasureTime frame
serum total bilirubin at 24 hours of starting phototherapyTimepoint: serum total bilirubin at 24 hours of starting phototherapy

Secondary

MeasureTime frame
1 Duration of phototherapy 2 Proportion of â??failure of single surface phototherapyâ?? 3 episodes of hypothermia and hyperthermia 4 Nursing staff comfort levelsTimepoint: From initiation to end of phototherapy

Countries

India

Contacts

Public ContactPraveen Kumar

PGIMER, Chandigarh

drpkumarpgi@gmail.com2755308

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026